Leila Pirhaji: The medical potential of AI and metabolites
Leila Pirhaji uses artificial intelligence for drug discovery and the treatment of metabolic diseases. Full bio
Double-click the English transcript below to play the video.
to treat many diseases.
could have a significant role
of the population globally,
and leads to liver cancer
doesn't give us enough information
many other molecules in our body.
over 100,000 metabolites.
that is supersmall in their size.
fructose, fats, cholesterol --
in our metabolism.
from both our genes as well as lifestyle.
to find treatments for many diseases.
I left medical school,
algorithms to analyze biological data.
the metabolites in our body,
how they are changed in a disease
changes to treat them.
has done this before:
we can measure their molecular mass
10 molecules with the exact same mass,
identify all of them,
which could take decades
intelligence, or AI, platform, to do that.
information about metabolites
with other molecules.
as a meganetwork.
that are changed in a disease.
we don't know exactly what they are.
either the glucose, galactose or fructose.
all these ambiguities.
are connected to each other
what each metabolite mass is,
and other metabolites
of disease mechanisms
effective therapeutics to target that.
to bring this technology to the market
are working to discover
在 ReviveMed 生技公司
that metabolites are key drivers for,
by accumulation of fats,
of metabolites in the liver.
it's a huge epidemic with no treatment.
is just one example.
hundreds of other diseases
data about metabolites
how changes in metabolites
smarter and smarter
for the right patients.
ABOUT THE SPEAKERLeila Pirhaji - Biotech entrepreneur
Leila Pirhaji uses artificial intelligence for drug discovery and the treatment of metabolic diseases.
Why you should listen
Leila Pirhaji is the founder of ReviveMed, an AI platform that can quickly and inexpensively characterize large numbers of metabolites (small molecules like glucose or cholesterol) from the blood, urine and tissues of patients. This allows for the detection of molecular mechanisms that lead to disease and the discovery of drugs that target these disease mechanisms.
Leila Pirhaji | Speaker | TED.com